Delivery Order SPE2DB25D3306-SPE2DB26FUAPA
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $30,051.78 by the Defense Logistics Agency on October 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,970.74 by the Defense Logistics Agency for 90-count tablets of Jardiance 10 mg on August 13, 2025. This firm fixed-price contract is non-set-aside and competitively awarded, with an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency on August 26, 2025, for a supply of Jardiance 10 mg tablets (90-count). The contract carries a ceiling value of $11,245.36 under firm fixed-price terms, with an ultimate completion date of August 27, 2025. This award was issued under a non-set-aside procurement, reflecting open competition. The place of...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,024.03 by the Defense Logistics Agency on September 18, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract is non-set-aside and utilizes firm fixed pricing under a competitive delivery order arrangement, with an ultimate completion date of September 19, 2025. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Jardiance 10 mg tablets in a 90-count package. The award, valued at $2,531.61, represents a firm fixed-price delivery order with no set-aside designation and a completion date of September 23, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 15, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Jardiance 10 mg tablets (90-count packaging). The contract carries a ceiling value of $48,577.98 and employs firm fixed price terms with an ultimate completion date of August 18, 2025. This non-set-aside award was competitively awarded and represents a child delivery order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $8,158.93 on August 21, 2025, for the supply of Jardiance 25 mg tablets (90 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The company serves as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency for 30 tablets of Jardiance 10 mg, with a ceiling value of $10,510.63 and an ultimate completion date of September 15, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency (DLA) to supply 90 tablets of Jardiance 10 mg medication. This competitively awarded, non-set-aside contract carries a ceiling value of $36,770.17 and is scheduled for completion by September 11, 2025. The award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Jardiance 10 mg tablets in a 90-count package. The contract, awarded on August 20, 2025, carries a ceiling value of $2,429.65 and features firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, and the contract...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUAPADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,280.41 by the Defense Logistics Agency on October 30, 2025, for the supply of Jardiance 10 mg tablets (90-count). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military and federal healthcare systems, enabling the company to supply a vast portfolio of pharmaceutical products across multiple therapeutic domains. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements through competitive award processes and its critical role as a pharmaceutical prime vendor supporting Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 10/30/25 |